Quantcast

Latest Evaluation methods Stories

2014-10-08 12:32:38

APPLE VALLEY, Minn., Oct. 8, 2014 /PRNewswire/ -- Questar Assessment, Inc. (Questar), a leading educational assessment provider for states, school districts, and higher education institutions, announced today that Keith Koch has joined the organization as its new Chief Technology Officer (CTO). A recognized national expert on how people interact with virtual environments, Koch will apply his deep understanding of user-centered design to lead ongoing product development while...

2014-10-06 08:27:47

WAYNE, Pa., Oct. 6, 2014 /PRNewswire/ -- Bracket, a leading clinical trial specialty services provider, today announced the addition of Jeffrey W. Kinell as Chief Executive Officer and as a new member of its Board of Directors. Jeff brings more than 30 years of experience to Bracket, primarily in leadership positions in growth oriented, health services and pharmaceutical outsourcing firms. Most recently, Jeff was CEO of CRI Lifetree, a mid-size specialized research organization focused in...

2014-10-05 23:00:43

MarketOptimizer.org adds “Intermittent Claudication Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Intermittent Claudication. Dallas, Texas (PRWEB) October 05, 2014 New clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2014″ provides data on the Intermittent Claudication clinical trial scenario. This report provides elemental information and data...

2014-10-01 16:26:43

Global Clinical Trials Get Breakthrough Technology to Improve Signal Detection HAMILTON, N.J., Oct. 1, 2014 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders, announced the deployment of its groundbreaking Virgil Investigative Study Platform in multiple clinical trials worldwide. The Virgil platform, developed specifically for investigative sites,...

2014-10-01 08:30:24

-- Primary endpoint was met for 50 mg twice daily dosing -- FREMONT, Calif., Oct. 1, 2014 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C). Results from this study demonstrated statistically significant and...

2014-09-30 23:04:46

MarketOptimizer.org adds “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Idiopathic (Essential) Hypertension. Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014″ provides data on the Idiopathic (Essential) Hypertension clinical trial scenario. This report provides...

2014-09-30 23:03:49

MarketOptimizer.org adds “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Occlusive Arterial Disease (OAD). Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014″ provides data on the Occlusive Arterial Disease (OAD) clinical trial scenario. This report provides elemental...

2014-09-19 23:06:26

New Process Design: Simple Tools and Methods Columbus, OH (PRWEB) September 19, 2014 On Tuesday, September 30, MoreSteam.com’s President and CEO, Bill Hathaway, will speak to an audience of Lean Six Sigma professionals at the Engineering Lean & Six Sigma conference to be held in Orlando, Florida. Hathaway’s presentation will be on the topic of new process design. Although Lean Six Sigma has been around for more than 20 years, and Total Quality Management (TQM) has been around...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...

2014-09-16 12:34:37

CORALVILLE, Iowa, Sept. 16, 2014 /PRNewswire/ -- ACT Aspire, LLC launches Periodic Assessments, the second major component of the ACT Aspire Assessment System. ACT Aspire is the first digital, longitudinal assessment system to fully connect student performance with readiness benchmarks from elementary grades through high school. It now extends the understanding of student progress through optional Periodic Assessments. These are short-duration, revealing assessments that produce...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related